These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 39150581)
1. Identification of Novel Antileishmanial Chemotypes By High-Throughput Virtual and In Vitro Screening. Khan H; Hakami MA; Alamri MA; Alotaibi BS; Ullah N; Khan R; Khalid A; Abdalla AN; Wadood A Acta Parasitol; 2024 Sep; 69(3):1439-1457. PubMed ID: 39150581 [TBL] [Abstract][Full Text] [Related]
2. Identification of potential anti-leishmanial agents using computational investigation and biological evaluation against trypanothione reductase. Kuldeep J; R K; Kaur P; Goyal N; Siddiqi MI J Biomol Struct Dyn; 2021 Feb; 39(3):960-969. PubMed ID: 31984862 [TBL] [Abstract][Full Text] [Related]
3. Natural compounds from plants controlling leishmanial growth via DNA damage and inhibiting trypanothione reductase and trypanothione synthetase: an in vitro and in silico approach. Mehwish S; Khan H; Rehman AU; Khan AU; Khan MA; Hayat O; Ahmad M; Wadood A; Ullah N 3 Biotech; 2019 Aug; 9(8):303. PubMed ID: 31355112 [TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242 [TBL] [Abstract][Full Text] [Related]
6. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach. Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998 [TBL] [Abstract][Full Text] [Related]
7. Dual-target drugs against Leishmania donovani for potential novel therapeutics. Bora K; Sarma M; Kanaujia SP; Dubey VK Sci Rep; 2023 Oct; 13(1):18363. PubMed ID: 37884555 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Antileishmanial Activity and de Aquino TM; França PHB; Rodrigues ÉEES; Nascimento IJS; Santos-Júnior PFS; Aquino PGV; Santos MS; Queiroz AC; Araújo MV; Alexandre-Moreira MS; Rodrigues RRL; Rodrigues KAF; Freitas JD; Bricard J; Meneghetti MR; Bourguignon JJ; Schmitt M; da Silva-Júnior EF; de Araújo-Júnior JX Med Chem; 2022; 18(2):151-169. PubMed ID: 33593264 [TBL] [Abstract][Full Text] [Related]
10. Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues. Verma RK; Prajapati VK; Verma GK; Chakraborty D; Sundar S; Rai M; Dubey VK; Singh MS ACS Med Chem Lett; 2012 Mar; 3(3):243-7. PubMed ID: 24936236 [TBL] [Abstract][Full Text] [Related]
11. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase. Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517 [TBL] [Abstract][Full Text] [Related]
12. Multitarget anti-parasitic activities of isoquinoline alkaloids isolated from Hippeastrum aulicum (Amaryllidaceae). Bessa CDPB; Feu AE; de Menezes RPB; Scotti MT; Lima JMG; Lima ML; Tempone AG; de Andrade JP; Bastida J; Borges WS Phytomedicine; 2024 Jun; 128():155414. PubMed ID: 38503155 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397 [No Abstract] [Full Text] [Related]
14. Insights about resveratrol analogs against trypanothione reductase of da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445 [TBL] [Abstract][Full Text] [Related]
15. Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis. Rub A; Shaker K; Kashif M; Arish M; Dukhyil AAB; Alshehri BM; Alaidarous MA; Banawas S; Amir K Protein Pept Lett; 2019; 26(5):371-376. PubMed ID: 30827222 [TBL] [Abstract][Full Text] [Related]
16. Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approach. Herrera-Acevedo C; Dos Santos Maia M; Cavalcanti ÉBVS; Coy-Barrera E; Scotti L; Scotti MT Mol Divers; 2021 Nov; 25(4):2411-2427. PubMed ID: 32909084 [TBL] [Abstract][Full Text] [Related]